https://www.selleckchem.com/pr....oducts/crenolanib-cp
Also, the results of antihypertensive activity for both peptides showed that systolic blood pressure (SBP) and diastolic blood pressure (DBP) of the mice treated with the HL-7 and HL-10 peptides were significantly reduced in a dose-dependent manner (p 0.01). The administration of the HL-7 peptide at doses of 2mg/kg BW (LP1), 5mg/kg BW (-IP1) and 15mg/kg BW (HP1) significantly diminished the mean arterial blood pressure (MAP) by 11mmHg, 31mmHg and 40.47mmHg, respectively. Accordingly, treatment of mice with the HL-10 pe
Like
Comment
Share
